Table of Contents Table of Contents
Previous Page  803 / 1851 Next Page
Information
Show Menu
Previous Page 803 / 1851 Next Page
Page Background

Other options for concurrent CRT

Cisplatin versus MMC

5FU/MMC versus Cisplatin/MMC

(EORTC)

2 drugs versus 3 drugs (ACT II pilot)

Carboplatin/taxol

EGFR inhibition